Profiles

Keywords
Last Name
Institution

Amir Jaffer

Concepts (191)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Anticoagulants
32
2019
146
7.360
Why?
Perioperative Care
19
2017
75
5.220
Why?
Venous Thromboembolism
13
2019
53
4.260
Why?
Warfarin
17
2019
61
3.190
Why?
Thromboembolism
14
2015
38
3.110
Why?
Heparin, Low-Molecular-Weight
15
2015
24
2.570
Why?
Surgical Procedures, Operative
7
2017
38
2.020
Why?
Venous Thrombosis
9
2017
47
1.640
Why?
Atrial Fibrillation
9
2016
191
1.570
Why?
Postoperative Complications
14
2015
1059
1.440
Why?
Hospital Medicine
2
2017
2
1.260
Why?
Quality of Health Care
3
2017
134
1.160
Why?
Hospitalists
2
2017
6
1.070
Why?
Polysaccharides
7
2009
15
1.050
Why?
Risk Factors
24
2017
2549
1.000
Why?
Hemorrhage
10
2019
87
1.000
Why?
Risk Assessment
16
2016
794
0.980
Why?
Elective Surgical Procedures
6
2017
53
0.910
Why?
Humans
57
2019
29841
0.870
Why?
Cardiac Surgical Procedures
3
2009
94
0.850
Why?
Platelet Aggregation Inhibitors
4
2013
64
0.690
Why?
Heparin
5
2008
38
0.680
Why?
Gastrointestinal Hemorrhage
2
2015
29
0.670
Why?
Cooperative Behavior
1
2017
88
0.660
Why?
Hematologic Diseases
1
2016
18
0.660
Why?
Arthroplasty, Replacement, Hip
6
2019
819
0.660
Why?
Arthroplasty, Replacement, Knee
6
2019
646
0.620
Why?
Preoperative Care
4
2009
149
0.610
Why?
Quality Improvement
2
2016
169
0.600
Why?
Fibrinolytic Agents
5
2016
92
0.580
Why?
Withholding Treatment
2
2015
9
0.560
Why?
Postoperative Hemorrhage
2
2012
30
0.550
Why?
Hospitalization
4
2010
330
0.550
Why?
Postoperative Care
3
2009
138
0.540
Why?
Blood Coagulation Disorders
2
2016
16
0.540
Why?
Adrenergic beta-Antagonists
2
2014
45
0.530
Why?
Intraoperative Care
2
2009
58
0.480
Why?
Practice Guidelines as Topic
3
2015
382
0.470
Why?
Patient Care Team
2
2014
140
0.440
Why?
Female
22
2019
17657
0.430
Why?
Aged
17
2019
9833
0.410
Why?
Evidence-Based Medicine
4
2013
233
0.400
Why?
Patient Readmission
3
2017
111
0.370
Why?
United States
6
2017
2402
0.370
Why?
Myocardial Ischemia
1
2008
54
0.370
Why?
Thrombosis
3
2013
68
0.370
Why?
Physician's Role
1
2007
22
0.350
Why?
Hip Fractures
1
2006
30
0.330
Why?
Time Factors
7
2016
1894
0.330
Why?
Male
15
2019
17153
0.330
Why?
Administration, Oral
3
2016
164
0.320
Why?
Antithrombins
1
2005
6
0.310
Why?
Stroke
3
2016
340
0.310
Why?
Drug Administration Schedule
5
2014
265
0.300
Why?
Heart Failure
1
2008
222
0.300
Why?
Vena Cava Filters
3
2009
10
0.290
Why?
Incidence
4
2015
813
0.290
Why?
Hirudins
2
2014
2
0.280
Why?
International Normalized Ratio
2
2019
32
0.260
Why?
Aspirin
5
2012
86
0.250
Why?
Enoxaparin
3
2012
9
0.230
Why?
Societies, Medical
2
2013
202
0.230
Why?
Aged, 80 and over
7
2014
5016
0.210
Why?
American Heart Association
2
2009
33
0.210
Why?
Predictive Value of Tests
3
2016
617
0.210
Why?
Vitamin K
3
2012
8
0.200
Why?
Odds Ratio
5
2016
328
0.190
Why?
Length of Stay
2
2013
360
0.190
Why?
Intracranial Embolism and Thrombosis
1
1997
3
0.190
Why?
Puerperal Disorders
1
1997
9
0.180
Why?
Treatment Outcome
7
2016
3788
0.180
Why?
Ambulatory Care Facilities
1
2017
39
0.180
Why?
Heart Valve Prosthesis
3
2012
40
0.180
Why?
Lung Diseases
2
2014
55
0.170
Why?
Joint Commission on Accreditation of Healthcare Organizations
1
2016
7
0.170
Why?
Follow-Up Studies
3
2019
2017
0.170
Why?
Electrocardiography, Ambulatory
1
2016
23
0.170
Why?
Telemetry
1
2016
15
0.170
Why?
Primary Health Care
1
2017
95
0.160
Why?
Genotype
1
2017
435
0.160
Why?
Prognosis
3
2011
1025
0.160
Why?
Patient Selection
4
2016
249
0.150
Why?
Cardiovascular Diseases
3
2014
370
0.150
Why?
Heart Rate
1
2016
165
0.150
Why?
Retrospective Studies
6
2017
3303
0.150
Why?
Middle Aged
8
2017
11053
0.150
Why?
Renal Insufficiency, Chronic
2
2014
91
0.150
Why?
Pulmonary Embolism
1
2014
55
0.140
Why?
Comorbidity
2
2008
555
0.140
Why?
Pulmonary Surgical Procedures
1
2013
2
0.140
Why?
Cardiovascular Surgical Procedures
1
2013
6
0.140
Why?
Severity of Illness Index
3
2012
1220
0.140
Why?
Pyridines
2
2016
47
0.140
Why?
Neoplasms
2
2008
264
0.140
Why?
Chile
1
2013
1
0.140
Why?
Kidney Diseases
1
2014
143
0.130
Why?
Ambulatory Surgical Procedures
1
2013
79
0.130
Why?
Risk Reduction Behavior
3
2008
55
0.130
Why?
Adult
7
2017
9591
0.130
Why?
Stents
2
2012
157
0.120
Why?
Magnetic Resonance Imaging
1
1997
1220
0.120
Why?
Disease Management
2
2015
149
0.120
Why?
Myocardial Infarction
1
2011
188
0.110
Why?
Drug Synergism
1
2009
68
0.110
Why?
Premedication
2
2006
7
0.100
Why?
Medication Therapy Management
1
2008
6
0.100
Why?
Prodrugs
1
2008
5
0.100
Why?
Benzylamines
1
2008
11
0.100
Why?
Azetidines
1
2008
4
0.100
Why?
Ohio
1
2008
8
0.100
Why?
Benzimidazoles
1
2008
12
0.100
Why?
Age Factors
2
2014
912
0.090
Why?
Kaplan-Meier Estimate
2
2019
226
0.090
Why?
Stroke Volume
1
2008
57
0.090
Why?
Cause of Death
1
2008
73
0.090
Why?
Drug Monitoring
1
2007
28
0.090
Why?
Thrombolytic Therapy
1
2008
84
0.090
Why?
Colorado
1
2007
5
0.090
Why?
Evaluation Studies as Topic
1
2007
61
0.090
Why?
Echocardiography
1
2008
197
0.090
Why?
Chemoprevention
1
2006
8
0.090
Why?
Cardiac Catheterization
1
2008
115
0.090
Why?
Delirium
1
2006
38
0.090
Why?
Survival Rate
1
2008
464
0.080
Why?
Bariatric Surgery
1
2006
39
0.080
Why?
Lung
1
2006
164
0.080
Why?
Primary Prevention
1
2006
41
0.080
Why?
Intraoperative Complications
1
2006
75
0.080
Why?
Probability
1
2005
107
0.080
Why?
Survival Analysis
1
2006
390
0.080
Why?
Secondary Prevention
1
2005
62
0.070
Why?
Disease Progression
1
2008
843
0.070
Why?
Postmenopause
1
2004
66
0.070
Why?
Prospective Studies
1
2010
1809
0.070
Why?
Orthopedic Procedures
1
2008
316
0.070
Why?
Hormone Replacement Therapy
1
2004
37
0.070
Why?
Geriatric Assessment
1
2006
229
0.070
Why?
Endoscopy, Gastrointestinal
1
2003
12
0.070
Why?
Decision Making
1
2006
222
0.070
Why?
Clinical Trials as Topic
2
2005
382
0.070
Why?
Clinical Protocols
1
2003
74
0.070
Why?
Recombinant Proteins
2
2014
306
0.070
Why?
Randomized Controlled Trials as Topic
2
2016
357
0.060
Why?
Injections, Subcutaneous
2
2012
44
0.060
Why?
Proportional Hazards Models
1
2019
379
0.050
Why?
Adolescent
2
2012
2591
0.050
Why?
Appointments and Schedules
1
2017
15
0.050
Why?
Jugular Veins
1
1997
6
0.050
Why?
Drug Interactions
1
2017
71
0.050
Why?
Cranial Sinuses
1
1997
9
0.050
Why?
Magnetic Resonance Angiography
1
1997
51
0.050
Why?
Medicaid
1
2017
41
0.040
Why?
Pyridones
1
2016
18
0.040
Why?
Medicare
1
2017
99
0.040
Why?
Thiazoles
1
2016
39
0.040
Why?
Regression Analysis
1
2017
318
0.040
Why?
Signal Processing, Computer-Assisted
1
2016
44
0.040
Why?
Pyrazoles
1
2016
48
0.040
Why?
Focus Groups
1
2016
90
0.040
Why?
Double-Blind Method
2
2015
541
0.040
Why?
Perioperative Period
1
2015
13
0.040
Why?
Consensus
1
2016
90
0.040
Why?
Global Health
1
2015
57
0.040
Why?
Clonidine
1
2014
31
0.040
Why?
Delivery of Health Care
1
2016
110
0.040
Why?
Smoking Cessation
1
2014
50
0.040
Why?
Pulmonary Disease, Chronic Obstructive
1
2014
40
0.040
Why?
Cross-Sectional Studies
1
2017
915
0.040
Why?
Acute Kidney Injury
1
2014
58
0.040
Why?
Heart Arrest
1
2014
52
0.040
Why?
Sleep Apnea, Obstructive
1
2014
66
0.040
Why?
Postoperative Period
1
2014
291
0.030
Why?
Multicenter Studies as Topic
1
2012
68
0.030
Why?
Case-Control Studies
2
2004
684
0.030
Why?
Health Knowledge, Attitudes, Practice
1
2014
223
0.030
Why?
Angioplasty, Balloon, Coronary
1
2012
54
0.030
Why?
Hypertension, Pulmonary
1
2011
26
0.030
Why?
Logistic Models
1
2012
478
0.030
Why?
Ticlopidine
1
2008
15
0.020
Why?
Butanones
1
1987
1
0.020
Why?
Health Personnel
1
2008
94
0.020
Why?
Dose-Response Relationship, Drug
1
2008
524
0.020
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
1987
106
0.020
Why?
Young Adult
1
2012
2198
0.020
Why?
Drug Evaluation
1
2004
58
0.020
Why?
Time
1
2004
22
0.020
Why?
Acute Disease
1
2004
272
0.020
Why?
Osteoarthritis
1
1987
354
0.020
Why?
Multivariate Analysis
1
2004
390
0.020
Why?
Patient Dropouts
1
1987
31
0.010
Why?
Random Allocation
1
1987
162
0.010
Why?
Jaffer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description